Sign in
4

Changes in Ownership

ClearPoint Neuro, Inc. Filed Acc 0001285550-22-000024

GM, Biologics & Drug Delivery acquired 17,528 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

STIGALL L. JEREMY · GM, Biologics & Drug Delivery

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-06-10 Grant or award : show line 1 in the form +17,528 43,211 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-06-10 Grant or award : show line 2 in the form Stock Option (Right to Buy) +11,685 11,685 D
Loading xslF345X03/wf-form4_165523772954876.xml…